| Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. | |
| | |
MedLine Citation:
|
PMID: 12776476 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Use of dextrose prolotherapy. Prolotherapy is defined as injection that causes growth of normal cells or tissue. OBJECTIVE: Determine the 1 and 3 year efficacy of dextrose injection prolotherapy on anterior cruciate ligament (ACL) laxity. After year 1, determine patient tolerance of a stronger dextrose concentration (25% versus 10%). DESIGN: Prospective consecutive patient trial. SETTING: Outpatient physical medicine clinic. PATIENTS OR OTHER PARTICIPANTS: Eighteen patients with 6 months or more of knee pain plus ACL knee laxity. This laxity was defined by a KT1000 anterior displacement difference (ADD) of 2 mm or more. INTERVENTION: Intraarticular injection of 6-9 cc of 10% dextrose at months 0, 2, 4, 6, and 10. Injection with 6 cc of 25% dextrose at 12 months. Then, depending on patient preference, injection of either 10% or 25% dextrose every 2-4 months (based on patient preference) through 36 months. MAIN OUTCOME MEASURES: Visual analogue scale (VAS) for pain at rest, pain on level surfaces, pain on stairs, and swelling. Goniometric flexion range of motion, and KT1000-measured ADD were also measured. All measurements were obtained at 0, 6, 12 and 36 months. RESULTS: Two patients did not reach 6 month data collection, 1 of whom was diagnosed with disseminated cancer. The second was wheelchair-bound and found long-distance travel to the clinic problematic. Sixteen subjects were available for data analysis. KT1000 ADD, measurement indicated that 6 knees measured as normal (not loose) after 6 months, 9 measured as normal after 1 year (6 injections), and 10 measured as normal at 3 years. At the 3 year follow-up, pain at rest, pain with walking, and pain with stair use had improved by 45%, 43%, and 35% respectively. Individual paired t tests indicated subjective swelling improved 63% (P = .017), flexion range of motion improved by 10.5 degrees (P = .002), and KT1000 ADD improved by 71% (P = .002). Eleven out of 16 patients preferred 10% dextrose injection. CONCLUSION: In patients with symptomatic anterior cruciate ligament laxity, intermittent dextrose injection resulted in clinically and statistically significant improvement in ACL laxity, pain, swelling, and knee range of motion. |
| | |
Authors:
|
K Dean Reeves; Khatab M Hassanein |
Related Documents
:
|
15995446 - Implications of the pivot shift in the acl-deficient knee. 19132346 - Epidemiologic, clinical and arthroscopic study of the discoid meniscus variant in greek... 16923826 - A prospective, randomized comparison of semitendinosus and gracilis tendon versus patel... 6829276 - Prospective stress radiography in 38 old injuries of the ligaments of the knee joint. 15572966 - The effect of fasting practice on sedation with chloral hydrate. 19924436 - An evaluation of the utility of additional tests in the preoperative diagnostics of acu... |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Alternative therapies in health and medicine Volume: 9 ISSN: 1078-6791 ISO Abbreviation: Altern Ther Health Med Publication Date: 2003 May-Jun |
Date Detail:
|
Created Date: 2003-06-02 Completed Date: 2003-07-17 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9502013 Medline TA: Altern Ther Health Med Country: United States |
Other Details:
|
Languages: eng Pagination: 58-62 Citation Subset: IM |
Affiliation:
|
Department of Biometry, University of Kansas Medical Center, Kansas City, Kan., USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anterior Cruciate Ligament / physiopathology* Female Follow-Up Studies Glucose / administration & dosage* Growth Substances / administration & dosage* Homeopathy* / methods Humans Injections, Intra-Articular Joint Instability / drug therapy*, physiopathology, prevention & control Male Middle Aged Osteoarthritis, Knee / drug therapy*, physiopathology Pain Measurement Prospective Studies Severity of Illness Index Time Factors Treatment Outcome Walking |
| Chemical | |
Reg. No./Substance:
|
0/Growth Substances; 50-99-7/Glucose |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of complementary and alternative medicine among the ethnic elderly.
Next Document: Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.